Ligustrazine Phosphate Capsules
Function and Efficacy
Ligustrazine phosphate has the effects of anti-platelet aggregation, dilating arterioles, improving microcirculation and promoting blood circulation and removing blood stasis, and has the effect of disaggregating aggregated platelets.
Ingredients
The main ingredient of this product is ligustrazine phosphate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LigustrazinePhosphateIngredients |
It has the effects of anti-platelet aggregation, dilating arterioles, improving microcirculation and promoting blood circulation and removing blood stasis, and has the effect of disaggregating aggregated platelets. More |
848645-86-3 | 6 |
Appearance
This product is a hard capsule, and the contents are white or off-white powder.
Indication
Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by insufficient blood supply to the brain, cerebral thrombosis, and cerebral embolism.
Usage and Dosage
Take orally 50-100 mg (1-2 tablets) 3 times a day. One course of treatment is 1 month.
Adverse Reactions
Occasionally, stomach discomfort, dry mouth, and drowsiness may occur. Taking the medicine after meals can avoid or reduce side effects.
Precautions
It is contraindicated in patients with cerebral hemorrhage or bleeding tendency.
Special Population Medication
Precautions for children: Please follow the doctor's advice. Precautions for pregnancy and lactation: Use with caution for pregnant or lactating women. Precautions for the elderly: Please follow the doctor's advice.
Drug Interactions
This product is highly acidic and should not be used in combination with alkaline drugs.
Storage
Store in a dry place.
Packaging Specification
50mg
Validity Period
24 months
Manufacturer
Qinghai Kekexili Pharmaceutical Group Co., Ltd.
-
Founded in:
2005-06-22 -
Address:
No. 9, Jinger Road, Qinghai Biotechnology Industrial Park -
Tax NO.:
91633100757431769A -
Registered Funds:
30 million yuan -
Website:
-
Email: